PCOS and Endometriosis Trying to Conceive: How Often, and What Changes

How Often Do PCOS and Endometriosis Actually Co-Occur in Women Trying to Conceive?

A nationwide cohort of 157,662 Korean women aged 15 to 45 found that PCOS and endometriosis rarely occur in the same person, each tracking a different set of comorbidities rather than compounding each other. PCOS correlated with metabolic conditions — dyslipidaemia, type 2 diabetes, pregnancy-related complications, gastrointestinal issues. Endometriosis correlated with pain-related diagnoses, benign reproductive-organ growths, and endometrial hyperplasia. The study’s own conclusion is direct: the two are “prevalent gynecological disorders affecting similar age groups of women” that “rarely co-occur and exhibit unique comorbidity profiles.” If you are trying to conceive and wondering whether you might have both conditions, the base rate itself argues against assuming so.

One finding cuts against that separation, though, and it is the one that matters for this article: infertility was among the few diagnoses significantly associated with both PCOS and endometriosis in that same cohort. That is not evidence the two conditions travel together — it is evidence that struggling to conceive is a shared complaint that can point to either condition, sometimes neither, and occasionally both, which is exactly why a fertility work-up cannot assume a single diagnosis just because a woman is having trouble conceiving. A full feature-by-feature comparison of what actually separates the two conditions — cycle pattern, pain pattern, ultrasound findings — is covered on this site’s PCOS-vs-endometriosis comparison, and this article does not repeat it; what follows is specific to what happens when a fertility work-up has to consider both possibilities at once.

PCOS was renamed polyendocrine metabolic ovarian syndrome (PMOS) in May 2026 by a global consensus of more than 50 organisations — same condition, same mechanism, only the label changed. This article uses PCOS throughout, since that is still the term most people search.

Why Does Endometriosis Take So Long to Diagnose While You Are Trying to Conceive?

A multicenter study spanning 16 clinics across ten countries found a 6.7-year average gap between symptom onset and surgical diagnosis of endometriosis, in a prospective sample of 1,418 women — longer where care was predominantly state-funded (8.3 years) than where it was not (5.5 years). A more recent systematic review of 17 studies since 2018 found diagnosis times still ranging from 0.3 to 12 years depending on how the delay is defined and where a woman lives, and concluded that diagnostic delay “is still present, primarily driven by physicians.” This is not old, resolved history. It is a documented pattern that has not gone away, and a reader whose pain has been waved off for years by more than one clinician is describing something the literature backs up, not something she is overreacting to.

PCOS makes that delay easier to miss in a specific way worth naming directly: many PCOS cycles are anovulatory, and anovulation removes the post-ovulatory progesterone surge that normally drives classic period cramping. That can genuinely blunt pain in PCOS — but it also means that if endometriosis is present too, the progressive, cycle-linked pain that would normally prompt a referral has one more reason to be dismissed as “just PCOS” rather than investigated as something separate. How ordinary PCOS-related pelvic pain actually feels, and which patterns are worth raising with a doctor, is covered in full in this site’s guide to PCOS period pain — worth reading directly if pain, not cycle irregularity, is your main concern.

None of this means pain proves endometriosis is present. Pain patterns — progressive, cyclical, worse with sex or bowel movements — are suggestive, not diagnostic; endometriosis is confirmed through imaging findings or surgical visualisation, not through a symptom description alone, however consistent. Treat a matching pain pattern as a strong reason to ask for evaluation, not as a conclusion to carry into an appointment already reached.

How Does PCOS Point a Fertility Work-Up Toward Ovulation Induction?

PCOS disrupts ovulation in most diagnosed cycles, which is why both the 2023 international guideline and a landmark 750-woman randomized trial center PCOS fertility treatment on restarting egg release rather than on pelvic anatomy. Letrozole produced a live birth in 27.5% of participants compared with 19.1% on clomiphene across up to five treatment cycles — the finding most responsible for guidelines now listing letrozole as the preferred first medication for ovulation induction in PCOS. Every participant in that trial had already been confirmed to have a patent fallopian tube, a normal uterine cavity, and a partner with a documented sperm count — standard checks done regardless of the PCOS diagnosis, not skipped because anovulation looked like the obvious explanation.

That baseline matters for the tension this article is about: ovulation-induction medication assumes the rest of the reproductive tract is unobstructed. It restarts egg release; it does nothing about scarring, adhesions, or an endometrioma sitting on an ovary. Which specific medication, at what dose, and for how many cycles before reassessing is a decision a clinician makes with your own results in hand — not something a general article can specify in advance.

How Does Endometriosis Point a Fertility Work-Up Toward Laparoscopic Assessment?

In a randomized trial of 341 infertile women with minimal or mild endometriosis, laparoscopic removal of visible lesions raised the cumulative pregnancy rate to 30.7%, compared with 17.7% after a diagnostic laparoscopy alone, over 36 weeks of follow-up. That is the core evidence behind treating endometriosis-associated infertility as a structural and inflammatory problem rather than an ovulation problem: pregnancy improved after surgery in a population where anovulation was not the driver. The 2022 ESHRE endometriosis guideline lists surgical treatment and medically assisted reproduction as the two feasible approaches to endometriosis-associated infertility, and states plainly that existing evidence does not support one firm recommendation over the other across all cases — the choice depends on age, disease stage, ovarian reserve, and how long a couple has already been trying, weighed together by a specialist rather than read off a single rule.

The same guideline also challenges laparoscopy and histology as a mandatory first step for diagnosis generally, favouring imaging — transvaginal ultrasound or pelvic MRI — where a typical presentation allows treatment to start without surgery first. But imaging reliably finds only an endometrioma or deep infiltrating disease; it frequently misses the superficial lesions that were the population in the Marcoux trial above. That gap is precisely why a normal scan does not close the endometriosis question the way a mid-luteal progesterone test can close the anovulation question — the two conditions are not confirmed by parallel tests of equal reach.

Where the Two Work-Ups Actually Pull in Different Directions

A 30-study meta-analysis of AMH after endometrioma surgery found anti-Müllerian hormone (AMH) — a marker of ovarian reserve — drops significantly after laparoscopic cystectomy: by 1.39 ng/mL in the weeks after surgery, and by 2.12 ng/mL measured six to eighteen months out, across all follow-up windows the review examined. That finding was measured in women having surgery for an endometrioma generally, not specifically in women who also have PCOS, so it should be read as a general surgical effect rather than a PCOS-specific one. But the effect lands directly on the variable a PCOS ovulation-induction cycle depends on: how many follicles the ovary has left to recruit. Removing an endometrioma can be medically necessary — for pain, to rule out malignancy, or because a large cyst is in the way before egg retrieval — while also measurably reducing the exact reserve an ovulation-induction protocol is trying to work with.

That is the real tension a combined diagnosis creates, and it is not a sequencing question this article can answer. Whether surgery happens before, after, or alongside a course of ovulation induction depends on disease severity, cyst size, ovarian reserve already measured, age, and how each specific finding was reached — exactly the kind of individualised weighing the ESHRE guideline declines to reduce to one rule, and exactly what a reproductive endocrinologist and, where surgery is being considered, a gynaecological surgeon work out together with your own results.

What a Fertility Specialist Actually Weighs When Both Diagnoses Apply

Five separate pieces of information — confirmed ovulation status, ovarian reserve, pain pattern and severity, imaging or surgical findings, and how long you have already been trying — feed into one decision a specialist reaches case by case, not a fixed order this article can lay out in advance. What that first specialist visit actually covers, and the referral timelines PCOS itself already shortens, is addressed in full in this site’s fertility-specialist referral guide; everything in that guide applies whether or not endometriosis is also suspected, and having a second diagnosis in the picture is itself one of the standard reasons it lists for not waiting out the usual 12-month timeline.

What changes with two diagnoses is not the referral threshold but the number of specialists potentially involved: a reproductive endocrinologist manages the ovulation side, and a gynaecological surgeon becomes relevant if imaging or symptoms point toward disease severe enough to need surgical assessment. Which of those two conversations happens first, in parallel, or not at all is exactly the judgment call a specialist makes after seeing your own scans and hormone results — not a decision this article is positioned to make on your behalf.

What the Evidence Cannot Tell You Yet

Zero published trials have tested a fertility treatment protocol specifically in women diagnosed with both PCOS and endometriosis — every percentage in this article comes from a PCOS-only or an endometriosis-only study population, and nobody has isolated the combined group to see whether the two approaches interact, help each other, or work against each other in the same patient. That gap is worth naming plainly rather than papering over with confident-sounding advice this evidence does not support.

This article also does not diagnose endometriosis, and it should not be read as doing so. A cyclical pain pattern, a family history, or a slow pregnancy attempt are reasons to ask for evaluation — not findings that settle the question on their own. If diet is part of what you are trying to reconcile alongside a fertility work-up, this site covers how a PCOS diet and an endometriosis diet actually conflict separately, since nutrition evidence for each condition targets a different mechanism and the two do not fully agree.

Your Next Step

If you are trying to conceive and suspect both conditions, the single most useful thing to bring to an appointment is not a self-diagnosis but a clear description of two separate patterns: how predictable your cycles are, and whether pain builds progressively before and during a period independent of cycle length. Those are different questions pointing at different mechanisms, and naming them separately is what lets a specialist start the right tests for each rather than treating one as an explanation for the other. The fertility hub covers the wider work-up this page assumes as background.